Cart
sales@molnova.com
EJMC-1
CAS No. 397281-20-8
EJMC-1( N-(3-chloro-4-hydroxyphenyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide )
Catalog No. M28517 CAS No. 397281-20-8
EJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 329 | Get Quote |
|
| 5MG | 555 | Get Quote |
|
| 10MG | 791 | Get Quote |
|
| 25MG | 1152 | Get Quote |
|
| 50MG | 1575 | Get Quote |
|
| 100MG | 2133 | Get Quote |
|
| 500MG | 4275 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEJMC-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionEJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.
-
DescriptionEJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.
-
In Vitro——
-
In Vivo——
-
SynonymsN-(3-chloro-4-hydroxyphenyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
-
PathwayApoptosis
-
TargetTNF
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number397281-20-8
-
Formula Weight374.8
-
Molecular FormulaC17H11ClN2O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (333.51 mM)
-
SMILESOc1ccc(NS(=O)(=O)c2ccc3NC(=O)c4cccc2c34)cc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Physcion 8-O-β-D-glu...
Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.
-
Clematichinenoside A...
Clematichinenoside AR exerts anti-inflammatory and immunosuppressive properties, it has anti-arthritic effects on PI3K/Akt signaling pathway and TNF-α± associated with collagen-induced arthritis.
-
Tebentafusp
Tebentafusp (IMCgp100) is a protein that specifically targets gp100 and consists of a soluble T-cell receptor functionally fused to an anti-CD3 immune effector Tebentafusp has potential anti-tumor activity, induces the production of inflammatory cytokines and cytolytic proteins, and can be used to study unresectable or metastatic uveal melanoma.
